Combined modality therapy improves overall survival for angiosarcoma

Acta Oncol. 2017 Sep;56(9):1235-1238. doi: 10.1080/0284186X.2017.1306104. Epub 2017 Mar 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / therapeutic use
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Hemangiosarcoma / mortality*
  • Hemangiosarcoma / pathology
  • Hemangiosarcoma / therapy*
  • Humans
  • Male
  • Middle Aged
  • Radiotherapy / methods
  • Retrospective Studies
  • Sarcoma / mortality
  • Sarcoma / pathology
  • Sarcoma / therapy
  • Soft Tissue Neoplasms / mortality*
  • Soft Tissue Neoplasms / pathology
  • Soft Tissue Neoplasms / therapy*
  • Surgical Procedures, Operative / methods
  • Survival Analysis
  • Survival Rate
  • Treatment Outcome
  • Young Adult

Substances

  • Antineoplastic Agents